This is not the most recent version of the article. View current version (3 AUG 2014)
Fluphenazine versus low-potency first generation antipsychotic drugs for schizophrenia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 10 AUG 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Tardy M, Leucht S, Potapov A, Engel R, Huhn M, Kissling W. Fluphenazine versus low-potency first generation antipsychotic drugs for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD009230. DOI: 10.1002/14651858.CD009230.
- Publication Status: New
- Published Online: 10 AUG 2011
This is not the most recent version of the article. View current version (03 AUG 2014)
This is the protocol for a review and there is no abstract. The objectives are as follows:
Tor evaluate the effects of the high-potency antipsychotic drug fluphenazine versus low-potency antipsychotic drugs. Fluphenazine is clinically perceived to be more efficacious than other low-potency drugs, and in this review we will test the hypothesis that fluphenazine is more effective than other low-potency antipsychotic drugs.